Alexion - Among The Best Risk/Reward In Biotech?
Mid-cap Alexion (NASDAQ:ALXN), listed as the 9th most heavily-weighted stock in the iShares Nasdaq Biotech ETF (NASDAQ:IBB) (probably 8th now after jumping today), highlighted Q1 earnings and the running start that its new CEO has gotten on the company. The stock may be a large cap soon again at this rate (market cap above $30 B).